Oncology Biomarker Diagnostics

Linking molecular status to breakthroughs in cancer treatment

Scientific Advisors


Arul M. Chinnaiyan, M.D., Ph.D.
Director, University of Michigan Center for Translational Pathology


Brian Druker, M.D.
Director, Oregon Health and Science University Knight Cancer Institute

Oncology Thought Leaders Series:
Brian Druker, MD speaks on the value of
companion diagnostics in patient outcomes